Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Temasek Invests $800 Million in Google's Verily Life Sciences

publication date: Jan 26, 2017
Temasek, the sovereign wealth fund of Singapore, invested $800 million in Verily Life Sciences LLC of San Francisco. Verily is the former health sciences division of Google's R&D operations, now spun out into a separate company. For its $800 million, Temasek will own an unspecified minority stake in Verily. Verily aims to improve human health. So far, it has been involved in big data research and innovative medical products, especially those that provide real-time, continuous monitoring. Verily said Temasek brings valuable insight into foreign markets, especially in Asian countries. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital